Dr Agarwals Eye Hospital Ltd-$
Dr Agarwals Eye Hospital: Amalgamation with Health Care Limited Effective November 01, 2026
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 20 Oct 2026, 07:46 PM IST · BSE ID: b04d7164-60c6-4ad8-91a1-909efd568a6b
View Original BSE Filing (PDF)
💡
In Simple Terms
Two companies, Dr. Agarwals Eye Hospital and Dr. Agarwals Health Care, are merging, effective November 1, 2026.
🤖 AI Summary
- Scheme of Amalgamation between Dr. Agarwals Eye Hospital and Dr. Agarwals Health Care becomes effective November 01, 2026.
- November 18, 2026, fixed as Record Date for allotment of consideration shares under the Scheme.
- Share exchange ratio: 23 equity shares of Dr. Agarwals Health Care for every 2 equity shares of Dr. Agarwals Eye Hospital.
- Dr. Agarwals Eye Hospital Limited (Transferor Company) to be dissolved without winding-up from November 01, 2026.
- NCLT Order sanctioning the Scheme, dated September 30, 2026, was filed with ROC on October 14, 2026.
🏢 How This Affects the Company
The amalgamation will integrate the business operations of Dr. Agarwals Eye Hospital into Dr. Agarwals Health Care Limited, consolidating their market presence.
Dr. Agarwals Eye Hospital Limited will cease to exist as a separate entity, with its assets and liabilities transferring to Dr. Agarwals Health Care Limited.
The corporate structure of Dr. Agarwals Eye Hospital Limited will be absorbed, leading to the dissolution of its Board of Directors from November 01, 2026.
The completion of the amalgamation removes the execution risk associated with the merger process, leading to a streamlined corporate structure.
👥 What This Means For Shareholders
✅
Action Required
Shareholders of Dr. Agarwals Eye Hospital Limited must hold their shares until November 18, 2026 (Record Date) to be eligible for consideration shares.
👤
Who Is Affected
All eligible equity shareholders of Dr. Agarwals Eye Hospital Limited holding shares on November 18, 2026, will receive 23 equity shares of Dr. Agarwals Health Care Limited for every 2 shares held.
🔍
Management Signal
The Board's actions confirm the management's commitment to completing the previously announced amalgamation as per regulatory and NCLT approvals.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Confirmation of share allotment to eligible shareholders post November 18, 2026 Record Date.
Subsequent regulatory filings regarding the status of the amalgamated entity.
Disclosure of financial results for the newly unified entity in upcoming periods.
LOW RISK
The amalgamation process has successfully reached its effectiveness stage, reducing procedural risks.
💡 Investor Takeaway
The Scheme of Amalgamation involving Dr. Agarwals Eye Hospital Limited is effective November 01, 2026. A Record Date of November 18, 2026, is set for shareholders to receive 23 shares of Dr. Agarwals Health Care Limited for every 2 shares of Dr. Agarwals Eye Hospital Limited.
⚖️ Strengths & Concerns
✅ Positives
- Scheme of Amalgamation effective November 01, 2026, provides clarity on the integration process of the entities.
- Fixed Record Date of November 18, 2026, offers a clear timeline for shareholders to receive new consideration shares.
📅 Company Track Record
Previous filings indicated the NCLT, Chennai Bench, directed meetings for the Dr. Agarwals Eye Hospital amalgamation scheme on July 02, 2026. Subsequently, the NCLT order sanctioning the scheme was received.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When does the amalgamation of Dr. Agarwals Eye Hospital Limited become effective?
The Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited becomes effective and operative from November 01, 2026 (Effective Date).
What is the Record Date for share allotment in the amalgamation?
Wednesday, November 18, 2026, has been fixed as the Record Date for determining eligible equity shareholders to receive consideration shares.
What is the share exchange ratio for the amalgamation?
Eligible shareholders will receive 23 fully paid-up Equity Shares of face value of ₹1 each of Dr. Agarwal’s Health Care Limited for every 2 fully paid-up Equity Shares of face value of ₹10 each held in Dr. Agarwal’s Eye Hospital Limited.
What happens to Dr. Agarwals Eye Hospital Limited after the amalgamation?
Upon the Scheme becoming effective on November 01, 2026, Dr. Agarwals Eye Hospital Limited (Transferor Company) shall stand dissolved without being wound-up, and its Board of Directors shall cease to exist.
Questions based on this BSE filing only. For information purposes.